Who
Mark Earl Hensley
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Heron Therapeutics.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 May 2025
- Last trade
- 6 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 10 Aug 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code M | —31,250 | filing |
| 6 Aug 2026filed 10 Aug 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code F | $4,4448,888 at $0.50 | filing |
| 6 Aug 2026filed 10 Aug 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —31,250 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —31,250 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code M | —31,250 | filing |
| 6 Aug 2026filed 10 Aug 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code F | $4,4448,888 at $0.50 | filing |
| 31 Jul 2026filed 3 Aug 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code M | —11,769 | filing |
| 31 Jul 2026filed 3 Aug 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,769 at $0.00 | filing |
| 31 Jul 2026filed 3 Aug 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,769 at $0.00 | filing |
| 31 Jul 2026filed 3 Aug 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code M | —11,769 | filing |
| 6 May 2026filed 7 May 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code M | —125,000 | filing |
| 6 May 2026filed 7 May 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —125,000 at $0.00 | filing |
| 6 May 2026filed 7 May 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —125,000 at $0.00 | filing |
| 6 May 2026filed 7 May 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code M | —125,000 | filing |
| 30 Apr 2026filed 4 May 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code M | —11,770 | filing |
| 30 Apr 2026filed 4 May 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,770 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,770 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code M | —11,770 | filing |
| 30 Jan 2026filed 3 Feb 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —188,315 at $0.00 | filing |
| 30 Jan 2026filed 3 Feb 2026 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —188,314 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.